… on previous studies, 2 it was estimated that 60% of patients (n = 90) would have a PSA response
to induction chemotherapy and be randomized … in the previous series of chemotherapy. …

… We designed a randomized, multicentre, second-line clinical phase II study using paclitaxel
… metastatic melanoma who had received previous chemotherapy. These drugs were chosen …

… on the basis of the results of a randomized phase III study in which capecitabine-cisplatin …
The safety profile of bevacizumab in this study was also consistent with that of previous trials in …

… Our previous studies showed the high efficacy of gefitinib treatment in Taiwanese patients with
adenocarcinoma who failed previous chemotherapy.20… Randomized phase II clinical trials …

… Previous treatment with radiotherapy and/or systemic chemotherapy was a criterion of
exclusion. Patient age had to be less than 70 years and performance status had to be greater than …

… receiving adjuvant chemotherapy; age ranging from ≤18 to ≤80 yr; general condition 0 or
1 as per the World Health Organization scale; absence of previous chemotherapy for muscle-…

… as a randomized phase II trial and became a randomized phase III trial in April 1996. The
main objective was to evaluate antitumor activity (phase II) of and overall survival (phase III) …

… The addition of bevacizumab to chemotherapy did not statistically significantly increase the
risk of VTEs versus chemotherapy alone. The risk for VTEs is driven predominantly by tumor …

… Reasons for non-eligibility were the presence of metastatic disease at the time of
randomization (six patients), history of previous cancer, histological diagnosis of tumor other than …

… (AC), as primary chemotherapy for node-positive early stage breast cancer. In this phase-III
single center randomized study, we randomized 209 women with axillary node positive, …